BalkoResearchLab

@DelgiornoKathy @ScienceTM Thanks! It went through many, many rounds of reviews 😂

@BalkoLab @ScienceTM Congrats on a beautiful pub!

New from our lab in @ScienceTM: Peripheral blood transcriptional profiling predicts breast cancer tumor subtype and response to neoadjuvant chemoimmunotherapy.

This blood-based RNA sig achieves strong predictive performance, offering a non-invasive way to stratify patients, optimize therapy selection, and avoid unnecessary toxicity. science.org/doi/10.1126/sc… Huge congrats to the team! #BreastCancer #Immunotherapy #PrecisionMedicine

This was a collaborative effort across multiple institutions! A huge shout out to my twitterless co-first author Alan Gutierrez and my PI @CardioOncology, along with all co-authors and funding sources. @Pan_Ma_ @ScientistBaylis @LavineLab @BalkoLab @SarnoffCardio @czbiohub

New #JITC article: Monitoring systemic immune responses to checkpoint inhibition in breast cancer reveals host responses and mechanisms of resistance jitc.bmj.com/content/13/12/… @BCT255 @BalkoLab

New study 👉Dynamic single-cell systemic immune responses in immunotherapy-treated early-stage HR+ #BreastCancer patients. 🔓 pubmed.ncbi.nlm.nih.gov/40610460/ @MargaretAxelrod @stolaney1 @EMittendorfMD @BalkoLab

@Cancer_Cell Nice work! However this paper seems to avoid any mention of the wealth of information across tumor types demonstrating MHCII as a predictive biomarker for ICI therapy (10 years old in initial reporting). CD74 is essentially coregulated by CIITA so...??

A constitutive interferon-high immunophenotype defines response to immunotherapy in colorectal cancer dlvr.it/THwNgQ

Looks amazing! Great work @ECBrunner!

@Nole2death @apolo_andrea Cars were invented in the 1880s and remain today the most frequent use of transportation. There have been no advances in transportation in the last 150 years. Chemotherapy is a broad term for literally 100s of drugs, most discovered in the last 40. It's cool, good work. 👍🏼

@apolo_andrea Its crazy how much money is spent on "cancer research" year after year and the best option to fight cancer, Chemotherapy, was invented in 1940s. 80 years of research since and we haven't figured out anything.

State of the Art: The Winding Road of Immune Biomarkers in Early Breast Cancer—Roberto Salgado, Justin Balko, and Priyanka Sharma will address this topic in this special session at #SABCS24 (December 10-13). Learn more: bit.ly/3BjXxfB @BalkoLab @psharmalab

State of the Art: The Winding Road of Immune Biomarkers in Early Breast Cancer— Roberto Salgado, Justin Balko, and Priyanka Sharma will address this topic in this special session at #SABCS24 (December 10-13). Learn more: bit.ly/4h3tAR0 @BalkoLab @psharmalab

Next, @MargaretAxelrod talks about patient and tumor specific biomarkers in ici myocarditis👌 #gcos #gcos24 @ICOSociety @BalkoLab @CardioOncology

As we better understand mechanisms that may drive ICI-myocarditis, we can think of more targeted therapies! Work by many individuals including @DrJESalem @JimAllisonPhD @CardioOncology @BalkoLab have led to ideas of targeting CD80/86, JAK-STAT signaling pathways, and T-cells! 6/

Meet Immuno-oncology Senior Editor Justin M. Balko, PharmD, PhD. The @BalkoLab is focused on improving treatment outcomes in BC & other solid tumors, as well as the intersection between immunotherapy and tumor biology. Read the latest articles: bit.ly/3Lajnn3

@StoverLab I just email the SRO right away and ask them how I did

Is there a minimum (or maximum??) number of times one should refresh ERA Commons in the 72h after study section? 🖥️ Asking for a friend... 🤷‍♂️😂 #SciTwitter

#ASCO24 Poster Session | Analysis of the sensitivity to endocrine therapy assay in the PALLAS adjuvant trial of palbociclib in HR+/HER2- #breastcancer (ABCSG-42/AFT-05/BIG-14-13). @Otto_DFCI @elmayermd @MichaelGnant @AngieDemichele @ChristinaCurtis @cncurtis @BalkoLab

@StoverLab @ASCO @OSUCCC_James @FilipaLynce @DFCI_BreastOnc @AngieDemichele @PennCancer @DrSGraff @BrownUCancer Congrats Dan!!!

Incredibly honored to be named a Fellow of @ASCO #ASCO2024 - an org I believe in & gained so much from. Even better to be inducted w many amazing colleagues! Claire Verschraegen @OSUCCC_James @FilipaLynce @DFCI_BreastOnc @AngieDemichele @PennCancer @DrSGraff @BrownUCancer

Komen grantee @BalkoLab presents his work on understanding and improving #breastcancer response to immunotherapy @ #AACR24. To learn more, check out the MBC Impact Series where he discussed his work: bit.ly/4cFtpsN

So proud of this outstanding scientist and person @BCT255 defending her thesis today. A @SusanGKomen ASPIRE scholar, @CD_AACR @jitcancer published author and all around superstar. Can't wait to see what the future holds!! @VUMCResearch @VUBasicSciences

This line up!!! Phenomenal. @sitcancer Spring Scientific. Happening NOW!